热门资讯> 正文
2025-07-30 04:12
Teladoc Health (NYSE: TDOC) narrows FY2025 GAAP EPS guidance from $(1.40)-$(0.90) to $(1.35)-$(1.00) vs $(1.08) analyst estimate. Narrows FY2025 sales outlook from $2.468 billion-$2.576 billion to $2.501 billion-$2.548 billion vs $2.517 billion estimate.